1-3 of 3
Nathan Hall, MD, PhD
Close
Sort by
Journal Articles

Interim FDG PET Imaging in CALGB 50203 Trial of Stage I/II Non-Bulky Hodgkin Lymphoma: Would Using Combined PET and CT Criteria Better Predict Response Than Each Test Alone?,

Lale Kostakoglu, MD, MPH, Heiko Schoder, MD, Nathan Hall, MD, PhD, David J. Straus, MD, Jeffrey L Johnson, PhD, Lawrence Schwartz, MD, Ann LaCasce, MD, Sin-Ho Jung, PhD, Nancy L. Bartlett, MD, George P. Canellos, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2011) 118 (21): 3644.
https://doi.org/10.1182/blood.V118.21.3644.3644
Published: 2011
Journal Articles

The Prognostic Value of FDG PET/CT Prior to Autologous Stem Cell Transplant in Mantle Cell Lymphoma

Jonathon B. Cohen, MD, Nathan Hall, MD, PhD, Amy S. Ruppert, MAS, Jeffrey A. Jones, MD, MPH, Pierluigi Porcu, MD, Robert A. Baiocchi, M.D., Ph.D., Sam Penza, MD, Don M Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Joseph M. Flynn, DO, MPH, Steven M. Devine, MD, Kristie A Blum, MD
Journal: Blood
Blood (2011) 118 (21): 3113.
https://doi.org/10.1182/blood.V118.21.3113.3113
Published: 2011
Journal Articles

Validation of the International Harmonization Project (IHP) Guidelines in Early Stage Hodgkin Lymphoma (HL) Treated with Adriamycin, Vinblastine and Gemcitabine (AVG) (CALGB 50203): Early Results.

Lale Kostakoglu, MD, MPH, David J. Straus, MD, Heiko Schòˆder, MD, Ann S. LaCasce, MD, Nancy L Bartlett, MD, Nathan Hall, MD, PhD, Jeffrey L Johnson, PhD, Sin-Ho Jung, PhD, George P. Canellos, MD, Lawrence H Schwartz, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2008) 112 (11): 1460.
https://doi.org/10.1182/blood.V112.11.1460.1460
Published: 2008